Jeff Pavell is Director of Hoth Therapeutics, Inc.. Currently has a direct ownership of 5,075 shares of HOTH, which is worth approximately $4,009. The most recent transaction as insider was on Dec 13, 2022, when has been sold 5,075 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.08K
0% 3M change
0% 12M change
Total Value Held $4,009

Jeff Pavell Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 13 2022
BUY
Grant, award, or other acquisition
-
5,075 Added 50.0%
5,075 Common Stock
JP

Jeff Pavell

Director
New York, NY

Track Institutional and Insider Activities on HOTH

Follow Hoth Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HOTH shares.

Notify only if

Insider Trading

Get notified when an Hoth Therapeutics, Inc. insider buys or sells HOTH shares.

Notify only if

News

Receive news related to Hoth Therapeutics, Inc.

Track Activities on HOTH